-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-outcomes_disposition-comments.pdf
January 15, 2015 - This type
of scenario is not unusual, but it becomes hard to parse out
the relative contributions of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_surveillance.pdf
January 01, 2013 - article on
using the Delphi method17 reported the results of a 38-member panel that agreed with a scenario
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/version-2-risk-of-reinfection-from-SARSCoV2.pdf
July 01, 2022 - Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review
Rapid Evidence Product
Version 2.0 (January 2022)
Risk of Reinfection From SARS-CoV-2 – An
Update of an Antibody Response Following
SARS-Co…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/version-2-risk-of-reinfection-from-SARSCoV2.pdf
July 01, 2022 - Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review
Rapid Evidence Product
Version 2.0 (January 2022)
Risk of Reinfection From SARS-CoV-2 – An
Update of an Antibody Response Following
SARS-Co…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01.pdf
May 01, 2005 - Regarding the magnitude of bias, an ideal scenario is when one can use existing research to
quantify
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
March 01, 2011 - Methods Guide
for Comparative Effectiveness Reviews
Handling Continuous Outcomes in Quantitative
Synthesis
ii
This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC)
under contract to the Agency for Healthcare …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2320
Published Online: October 12, 2016
Evidence Report/Technology Assessment Disposition of Comments Report
R…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - Methods White Paper: Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence
Methods White Paper
Improving the Utility of Evidence Synthesis for
Decision Makers in the Face of Insufficient
Evidence
Methods White Paper
Improving the Utility of Evidence Synthesis …
-
effectivehealthcare.ahrq.gov/products/childhood-depression/protocol
August 24, 2018 - Current Page Topic Timeline Jan. 31, 2018 Topic Initiated Aug. 24, 2018 Research Protocol Apr. 10, 2020 Systematic Review Depression in Children: Systematic Review
Research Protocol August 24, 2018 Download Main Document PDF 427.7 KB
I. Background and Objectives for the Systematic Review
Depressio…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
December 01, 2017 - A Framework for Conceptualizing Evidence Needs of Health Systems
Research White Paper
A Framework for Conceptualizing Evidence Needs of
Health Systems
Research White Paper
A Framework for Conceptualizing Evidence Needs of
Health Systems
Prepared for:
Agency for Health…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
December 01, 2011 - indeterminate observation) in this discussion
is most useful in that it can give a sense of
the “worst case scenario
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - both budesonide and conventional steroids, precision
seems clearly lacking (there is a worst case scenario
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
October 30, 2019 - Disposition of Comments CER 214 Stroke Prevention in Patients With Atrial Fibrillation
Source: https://effectivehealthcare.ahrq.gov/topics/stroke-afib-update/research-2018
Published Online: October 30, 2018
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title:
Stroke Prevention…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
August 06, 2018 - Evidence-based Practice Center Systematic Review Protocol: Depression in Children: Systematic Review
Source: www.effectivehealthcare.ahrq.gov
Published online: August 22, 2017
Evidence-based Practice Center Systematic Review Protocol
Project Title: Depression in Children: Systematic Review
I. Backgroun…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
April 01, 2013 - PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs
Future Research Needs Paper
Number 24
PCA3 Testing in the
Diagnosis and
Management of Prostate
Cancer: Future Research
Needs
Future Research Needs Paper
Number 24
PCA3 Testing in the Diagnosis and Management of
Prost…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_disposition-comments.pdf
June 10, 2013 - Including studies
that did not really target caloric consumption
sets up a false negative scenario
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
May 01, 2014 - In this scenario, the general public may only see a log-in screen when
they visit the Web site.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - The scenario described by this reviewer
pertains to nonsystematic assessment of
kidney function that
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
August 01, 2016 - 0.88), but the 95% CI only
minimally crossed the significance threshold (95% CI
0.77 to 1.02); this scenario
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - Risk would be elevated (RR 2.50; CI
0.79, 7.96) in the most conservative scenario, with four usual care